Investors Business Daily
21 Nov 2026, 16:10 UTC · 1h ago
Target, Biotech Lead 5 Stocks Showing Strength In Brutal Market
Impact · against what's priced in
The reported strength in Target, Visa, and Regeneron is largely non-catalytic as their current prices already incorporate the earnings recoveries and stability mentioned. The potential merger between CrowdStrike and Zscaler represents new, material strategic information not yet embedded in current valuations.
- V+0.00
Doesn't touch the price's assumptions
- In context
The mention of Visa thriving during a market meltdown provides no new data regarding the revenue growth or margin recovery required to move the price.





